Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca PLC
54.17
0.00 (0.0%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
AstraZeneca PLC AZN NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 54.17 20:00:00
Open Price Low Price High Price Close Price Prev Close
54.17
more quote information »

Recent News

Date Time Source Heading
3/22/202307:29EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/22/202307:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/13/202316:38EDGARSecurities Registration (section 12(b)) (8-a12b)
3/03/202316:34EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/02/202316:55EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
3/01/202311:53EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/01/202306:27EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
2/28/202310:19EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
2/21/202316:59EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/21/202308:25EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/13/202309:14EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/09/202308:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/24/202313:59EDGARAmended Statement of Ownership (sc 13g/a)
1/17/202310:26EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/11/202308:58EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/09/202308:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/30/202207:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/28/202206:44EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/28/202206:26EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/21/202206:37EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/21/202206:23EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/19/202208:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/19/202208:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/19/202207:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/19/202206:43EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/15/202206:42EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/29/202206:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/23/202210:40EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/14/202206:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/11/202206:43TRMNFDA Approves AstraZeneca’s (NASDAQ:AZN) Lung Cancer..
11/10/202208:06TRMNAstraZeneca (NASDAQ:AZN) Stock Rises on Upbeat Q3 Results,..
11/10/202207:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/09/202206:41EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/04/202208:51EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/01/202211:56EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/01/202205:08TRMNAstraZeneca’s COVID-19 Vaccine Granted Full Approval in EU
10/26/202207:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/25/202206:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/24/202207:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/03/202211:55EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/30/202206:24EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/27/202206:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/27/202206:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/22/202206:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/21/202206:19EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/20/202206:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/16/202207:30TRMNAstraZeneca (NASDAQ: AZN) Up on Positive Clinical Data and..
9/16/202206:51EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/16/202206:41EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/16/202206:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..